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Abstract
Cytomegaloviruses express large amounts of viral miRNAs during lytic infection, yet, they only modestly alter the cellular
miRNA profile. The most prominent alteration upon lytic murine cytomegalovirus (MCMV) infection is the rapid degradation
of the cellular miR-27a and miR-27b. Here, we report that this regulation is mediated by the ,1.7 kb spliced and highly
abundant MCMV m169 transcript. Specificity to miR-27a/b is mediated by a single, apparently optimized, miRNA binding
site located in its 39-UTR. This site is easily and efficiently retargeted to other cellular and viral miRNAs by target site
replacement. Expression of the 39-UTR of m169 by an adenoviral vector was sufficient to mediate its function, indicating that
no other viral factors are essential in this process. Degradation of miR-27a/b was found to be accompanied by 39-tailing and
-trimming. Despite its dramatic effect on miRNA stability, we found this interaction to be mutual, indicating potential
regulation of m169 by miR-27a/b. Most interestingly, three mutant viruses no longer able to target miR-27a/b, either due to
miRNA target site disruption or target site replacement, showed significant attenuation in multiple organs as early as 4 days
post infection, indicating that degradation of miR-27a/b is important for efficient MCMV replication in vivo.
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Introduction
MicroRNAs (miRNAs) are small non-coding RNA molecules,
which are involved in a broad range of biological processes. They
represent an evolutionary highly conserved mechanism present in
virtually all multicellular organisms ranging from fungi to
mammals (reviewed in [1]). MiRNA biogenesis is a stepwise
process involving the sequential action of the RNase III enzymes
Drosha and Dicer, generating a ,22 nucleotide (nt) miRNA
duplex. One strand of the duplex is then loaded into the RNA-
induced silencing complex (RISC), while the other strand, known
as the passenger strand or star sequence (miRNA*), is often, but
not always, actively degraded. Upon assembly into the RISC
complex, which invariably contains a member of the Argonaute
protein family, they regulate gene expression either via transla-
tional inhibition, and/or destabilization of the targeted transcript.
To date, more than 1,400 miRNAs have been identified in
humans [2]. Once incorporated into RISC, the loaded miRNA is
thought to be rather stable, with a half-life in the range of days [3].
In the last few years, tremendous progress has been made
regarding the functional role of miRNA-mediated regulation of
gene expression, resulting in the identification of thousands of
miRNA target sites [4–6]. However, much less is known about the
regulation of small RNAs themselves. Regulation of miRNA
expression levels has been described to occur at the level of
transcription, processing, and stability (reviewed in [1]). Never-
theless, the underlying molecular mechanisms are not always
clearly understood. As such, it has been reported that the
regulation of the maturation step of the let-7 miRNA precursor
is subject to regulation via the interaction of Lin28 with its terminal
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loop. After binding to the pre-miRNA, Lin28 recruits the terminal
uridyltransferase Zcchc11, which mediates tailing of the 39 end of
the small RNA [7–9]. The modification of small RNAs by
nucleotide addition is not only observed for pre-miRNAs, mature
miRNAs can also be modified. This was initially reported in the
plant model Arabidopsis thaliana, whereby miRNAs are usually
methylated at their 39 end by the methyl transferase HEN1 [10].
In a HEN1 mutant background, the absence of the 29-O-methyl
group on small RNAs triggers their 39 end tailing, usually by
uridylation, to bring about their degradation [11]. It has thus been
proposed that the 29-O-methylation of plant small RNAs, which
also occurs on animal Piwi-interacting RNAs (piRNAs) [12,13],
actually functions to protect the small RNAs against uridylation
and subsequent degradation. Recently, it was described that the
interaction between a small RNA and its target can in some cases
(extensive base pairing) also result in the degradation of the
miRNA [14]. Interestingly, this was found to be accompanied by
39-tailing and -trimming of the miRNA. However, the molecular
mechanisms involved still remain to be identified.
Regulation of miRNA expression occurs in response to both
biotic and abiotic stresses [15]. Among the former, viral infections
represent a prominent part and are known to interact extensively
with the RNA silencing machinery. In mammals, this is best
exemplified by the hijacking of the miRNA machinery by viruses,
especially herpesviruses, to express their own miRNAs [16]. The
use of small, non-immunogenic RNA molecules to regulate their
own, as well as cellular gene expression, is yet another illustration
of the extensive adaptation of these viruses to their hosts - the
result of millions of years of coevolution [17]. In addition to
expressing their own miRNAs, viruses also interact with cellular
miRNAs. For example, miR-32 plays an antiviral role upon
primate foamy virus infection [18], and both miR-24 and miR-93
negatively regulate the vesicular stomatitis virus [19]. A recent
study revealed a number of cellular miRNAs with apparently
intrinsic antiviral properties [20], highlighting the need for viruses
to engage in the alteration of the cellular miRNA profile. It is
therefore not surprising that the expression levels of some cellular
miRNAs are deregulated during viral infection.
Recently, we showed that lytic mouse cytomegalovirus
(MCMV) infection, besides expressing large numbers of viral
miRNAs [21], results in the dramatic destabilization of two
cellular miRNAs, namely miR-27a and miR-27b [22]. MiR-27a is
encoded within a miRNA cluster located on chromosome 8, along
with miR-23a and miR-24-2. It possesses an isoform located on
chromosome 13, miR-27b that is clustered with miR-23b and
miR-24-1. Strikingly, only the level of the mature forms of miR-
27a and 27b were affected upon MCMV infection, while the
levels of miR-27a* and miR-27b* remained unaltered. We thus
hypothesized MCMV to encode a transcript targeting miR-27a/b
for rapid degradation by a yet to be identified molecular
mechanism. Interestingly, during the course of this work Cazalla
et al. identified the herpesvirus saimiri HSUR1 transcript to bind
to, and target miR-27a/b for degradation [23].
Here, we report on the identification of the MCMV transcript,
encoded by the m169 gene, which mediates the rapid degradation
of both miR-27a and 27b. We found this down-regulation to be
accompanied by 39-tailing and -trimming of the miRNA.
Specificity to miR-27a/b is mediated via a single binding site
located in the m169 39-UTR. Replacement of this target site
allowed for efficient retargeting of the transcript to other cellular
and viral miRNAs. Despite its dramatic effect on miRNA stability,
we found this interaction to be mutual, resulting in miR-27a/b-
mediated regulation of m169. We thus performed infections of
mice with the mutant viruses we generated, which lost the ability
to degrade miR-27a/b, but retained regulation by a retargeted
cellular or viral miRNA. Results from these experiments reveal
that the interplay between the m169 transcript and cellular
miRNAs is important during acute MCMV infection in vivo.
Results
Degradation of miR-27a/b is mediated by a single
binding site in the MCMV m169 transcript
Upon lytic infection with the murine cytomegalovirus (MCMV),
large amounts of viral miRNAs are rapidly produced [21,24].
Recently, we reported that in addition to the expression of its own
viral miRNAs, MCMV infection triggers the rapid degradation of
two mature cellular miRNAs in various cell types, namely miR-
27a and miR-27b, [22]. These two cellular miRNAs show
complete sequence identity but for the nineteenth nucleotide
(‘‘C’’ for miR-27a and ‘‘U’’ for miR-27b). As both miRNAs
appeared to be similarly affected by MCMV, and because both
quantitative RT-PCR (qRT-PCR) and northern blot analysis
cannot properly distinguish miR-27a from miR-27b, we will refer
indiscriminately to both miRNAs as miR-27. In detail, their
degradation presented as a measureable decrease of the two
mature miRNAs within 4 hours of infection, ultimately leading to
an almost complete disappearance of miR-27 within two days of
infection. Blocking viral gene expression in MCMV infected cells
prevented miR-27 degradation [22]. It was thus tempting to
speculate that this massive, apparently sequence-specific degrada-
tion of two cellular miRNAs was mediated by a viral transcript
binding to the mature miRNAs, and subsequently targeting them
for degradation via a yet to be discovered molecular mechanism.
We decided to test this hypothesis by screening large deletion
mutants to identify the gene responsible for this function. We
started off with three MCMV mutants (D1,6; D1,7; D6,7) that we
previously generated [25], each lacking two of the three gene
blocks encompassing either MCMV genes m1–m16 (block 1),
m144–m159 (block 6) or m159–m170 (block 7). It is important to
note that none of these mutants shows any attenuation on NIH-
3T3 fibroblasts in vitro, while all three show severe growth defects in
vivo [25]. In order to ensure efficient infection of .99% of all cells,
we always infected NIH-3T3 fibroblast with a multiplicity of
infection (MOI) of 10 for 48 h, and determined changes in miR-27
Author Summary
MicroRNAs are small, non-coding RNAs which shape and
fine-tune gene expression of at least a third of our genes.
During millions of years of coevolution with their hosts,
herpesviruses have both usurped the host cell miRNA
machinery by expressing their own sets of miRNAs, and
learned to modify host miRNA expression for their own
needs. Recently, we reported on the rapid degradation of
two cellular miRNAs upon lytic murine cytomegalovirus
(MCMV) infection, namely miR-27a and miR-27b. In this
paper, we show that their regulation is mediated by the
highly abundant viral transcript m169. It targets miR-27a/b
via a single binding site in its 39-UTR, which can be
efficiently retargeted to other cellular and viral miRNAs,
enabling the efficient knock-down of individual miRNAs of
interest. Degradation of miR-27a/b is preceded by its 39-
tailing and -trimming. Most interestingly, three mutant
viruses unable to target miR-27a/b showed significantly
lower virus titers in various organs during acute MCMV
infection, indicating that degradation of miR-27a/b is
important for efficient virus replication in vivo.
Importance of miR-27 Degradation by MCMV In Vivo
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expression levels relative to miR-24 by quantitative RT-PCR
(qRT-PCR). We chose miR-24 for normalization as it is expressed
from the same pri-miRNA transcript as miR-27. In addition, we
found qRT-PCR CT values for miR-24 to be virtually identical to
miR-27 in uninfected cells, thus providing an ideal mean for
normalization using the DDCT -method. In accordance with our
previous observations [22], wild-type MCMV infection resulted in
a ,30-fold reduction in miR-27 levels compared to miR-24
(Figure 1A). While miR-27 degradation was still apparent with the
D1,6 mutant, both mutants lacking gene block 7 (m159–m170)
completely lost their ability to target miR-27 for degradation.
Therefore, degradation of miR-27 indeed appeared to be
mediated by a viral gene product. We thus generated and tested
a second set of smaller deletion mutants (D7S1, D7S2 and D7S3,
see Figure 1B), each lacking four MCMV genes of gene block 7.
The results obtained with these three mutant viruses, following the
same experimental setup as before, pinpointed the responsible
viral gene to m167–m170 (Figure 1C). Finally, we generated and
tested a third set of mutants (Dm167, Dm168, Dm169 and Dm170)
lacking the predicted coding sequences (CDS) of the correspond-
ing genes. Only the mutant lacking the predicted m168 CDS was
no longer able to target miR-27 for degradation (Figure 1D). We
thus looked for a putative binding site for miR-27 on either strand
of the genome within the 389 nt deletion of m168 using RNA-
hybrid [26]. Interestingly, this revealed a single binding site on the
strand opposite to m168, within the predicted 39-untranslated
region (UTR) of m169. The binding site consists of a perfect
match to the first 7 nt of miR-27a (6-mer seed match), a G-U
pairing at the 8th position, a 5 vs. 6 nt bulge (known to prevent
target degradation via Ago2 slicer activity), and a 7 nt perfect
match to the 39-end of the miRNA (including one G-U pairing
adjacent to the bulge) (Figure 1E). The one nucleotide difference
between miR-27a and miR-27b only results in a change from an
A-U to a G-U pairing, which was predicted by RNA-hybrid to
render the interaction to m169 slightly weaker for miR-27b than
for miR-27a (mean free energy (mfe) =223.5 kcal/mol vs.
225.7 kcal/mol). Markerless mutagenesis to introduce three single
point mutations into the seed region of the predicted binding site
(MCMV-m169-mut) (marked in Figure 1E) resulted in an almost
complete loss of miR-27 degradation from ,30-fold, down to ,2-
fold (Figure 1F). Degradation of miR-27 was completely restored
for the revertant virus. However, it is important to note that only
the middle one of these three point mutations actually disrupts
seed pairing, as both A-U and G-U pairings are known to support
RNA-RNA interactions, thus rendering the other two mutations
less potent. Therefore, a G-U wobble at position 2, and a single
mismatch in the middle of the seed region were sufficient to almost
completely abolish miR-27 degradation.
To get further insights into the characteristics of the m169
transcript, we made use of data generated by the Jonjic and
Trgovcich laboratories, which performed a large scale cDNA
cloning and sequencing study to comprehensively characterize the
MCMV transcriptome (Lisnic et al., manuscript in preparation). In
this study, a ,1.7 kb transcript containing the m169 open reading
frame (ORF) was identified (for transcript details see Figure S1).
This analysis also revealed a novel intron of 78 nt, located close to
the 39-end of the putative m169 CDS. The miR-27 binding site is
located 104 nt 39 of the m169 stop codon at the 59 end of the
m169 transcript 39-UTR. Quantitative RT-PCR revealed this
transcript to be already expressed at high levels within the first
hour of infection, exceeding IE1 transcripts by .2-fold within
4 hours of infection, and .20-fold at 48 hours post infection (hpi)
(Figure 1G).
Degradation of miR-27 by the m169 transcript involves
its 39-tailing and –trimming
Recently, it was reported that extensive complementarity
between a target RNA and a miRNA can result in post-
transcriptional modifications of the miRNA, mainly addition of
nucleotides at the 39 end of the small RNA (tailing), and shortening
of the sequence from its 39 extremity (trimming) [14]. We therefore
looked for post-transcriptional modifications of miR-27 at early
times of infection prior to its degradation. We infected NIH-3T3
cells with wild-type MCMV at an MOI of 10 and collected cells to
extract total RNA every hour from 1 to 5 hpi, and at 7, 9, 12, 24
and 48 hpi. We then performed high-resolution small RNA
northern blot analysis on these RNA samples and probed for miR-
27, miR-16 as well as the viral mcmv-miR-M23-2. As can be seen
on Figure 2A, miR-27 accumulated as four distinct bands in the
mock infected cells. During the first two to three hours of MCMV
infection, the pattern of miR-27 bands did not change, but after
four hours of infection additional bands started to appear, while
conjointly the expression level of the major band started to
decrease. The number of extra-bands visible on the miR-27 blot
culminated at 7 hpi before gradually decreasing again, the
quantification of the most prominent band showed that miR-27
was almost completely degraded by 48 hpi. The level of the
control miRNA miR-16 was not affected throughout the time
course, and the accumulation of the mcmv-miR-M23-2 occurred
as expected [21]. At the same time, we also measured the
accumulation of the viral transcript m169 and showed that it
started to become detectable by northern blot at 2 hpi, and was
abundantly expressed at 4 hpi, coinciding with the appearance of
additional bands in the miR-27 blot (Figure 2B).
In order to gain further insight into the level at which the
degradation of miR-27 occurs, we then performed Ago2
immunoprecipitation (IP) of NIH-3T3 cells infected with MCMV
at 6 and 12 hpi. We analyzed the accumulation of miR-27 in both
the total RNA and RNA isolated after Ago2 IP. Although the
resolution of this gel was not as good as in the previous northern
blot, we could still see some tailing of miR-27 in the total RNA at 6
and 12 hpi (Figure 2C). Interestingly, the extent of tailing seemed
to be lower in the RNA isolated from the Ago2 IP. In addition,
miR-27 levels decreased significantly more rapidly in the Ago2 IP
than in total RNA (Figure 2C), indicating that tailing of miR-27
might be accompanied by its displacement from Ago2 complexes
subsequently followed by its degradation, or that extensive tailing
occurred after displacement of miR-27 from Ago2.
We then set up to determine the nature of the modification of
miR-27a and miR-27b by performing small RNA cloning and
Illumina deep-sequencing using either total RNA extracted from
mock-infected NIH-3T3 cells, or from cells infected with MCMV
for 6 hours, as well as from RNA extracted after Ago2 IP from the
same samples. The analysis of miR-27a and miR-27b sequences in
the libraries revealed that in both mock- and MCMV-infected
cells, addition of non-templated nucleotides could be detected at
the 39 end, consistent with the northern blot data. Therefore, the
additional bands seen for miR-27 by northern blot represent 39-
tailing with non-templated nucleotides, rather than processing
isoforms. However, it is important to note that this feature was not
unique to miR-27, but also seen for other cellular miRNAs. As can
be seen in a sequence logo representation [27,28] of cloned miR-
27a and b in total RNA extracted from MCMV-infected cells, the
number of added nucleotides was greater for miR-27a (up to 3 nt
in the mock vs. 7nt in the infected cells) than miR-27b (2 nt in
mock vs. 4 nt MCMV infected cells respectively) (Figure 2D). The
number of sequences presenting with longer tails, however, was
lower for miR-27a than for miR-27b (Tables S1 and S2). The
Importance of miR-27 Degradation by MCMV In Vivo
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Figure 1. MCMV m169 transcript is targeting miR-27 via a single binding site in its predicted 39-UTR. A. Gene block 7 (m149–m170) is
crucial for miR-27 degradation. NIH-3T3 cells were infected with wild-type MCMV or three large deletion mutants each lacking two of the three gene
blocks 1 (m01–m16), 6 (m144–m158) or 7 (m159–m170) at an MOI of 10. 48 h post infection total RNA was isolated and miR-27 levels were quantified
relative to miR-24 by qRT-PCR. B. Genomic organization of gene block 7 and the three subdividing mutants. C. Degradation of miR-27 is mediated by
a gene located in between m167 and m170. The effect of the indicated mutants on miR-27 expression was determined as described above. D. The
genomic region encompassing the m168 coding sequence is essential for degradation of miR-27. The effect of the indicated mutants on miR-27
expression was determined as described above. This implicated either m168 or m169 to be implicated in miR-27 degradation. E. The binding site of
m169/miR-27a and miR-27b interactions. RNAhybrid predicted a single, well defined binding site for miR-27a/b in the predicted 39-UTR of the m169
transcript showing a typical match-bulge-match structure. The three point mutations introduced by markerless mutagenesis to create MCMV-m169-
mut are indicated. Only the middle one truly affects this interaction due to G:U A:U base pairing altered by the other two. In addition, the binding
site to miR-27b is shown with the single nucleotide difference to miR-27a indicated in bold italics. The mean free energy (mfe) of the interactions was
determined using RNAhybrid. F. Mutagenesis of the binding site abolished miR-27 degradation. The effect of the mutant virus and its revertant on
miR-27 levels were determined as described above. G. Expression levels of m169 and IE1 transcripts. NIH-3T3 fibroblasts were infected with WT
MCMV at an MOI of 10. At the indicated time points of infection total RNA was prepared. Expression levels of m169 and IE1 were determined by qRT-
PCR and normalized for Lamin B receptor (LBR) mRNA levels.
doi:10.1371/journal.ppat.1002510.g001
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Figure 2. Degradation of miR-27 is linked to its 39 -tailing and -trimming. A. Northern blot analysis of miR-27, miR-16, miR-M23-2 in NIH-3T3
cells infected with wild type MCMV (MOI = 10). The arrow indicates the prominent band representing the mature miR-27, which is quantified relative
to Mock (M) as indicated by the numbers below the blot. U6 snRNA was used as a loading control. B. Northern blot analysis of m169 transcript
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most prominent nucleotide added was an ‘A’, followed by a ‘U’.
Intriguingly, in Ago2 IP the difference in tailing between mock
and MCMV infected cells was neither evident for miR-27a nor
miR-27b, indicative of displacement of extensively tailed miRNAs
from Ago2, or conversely, tailing of miRNAs after displacement
from Ago2. To estimate the significance of the modifications of
miR-27 in MCMV infected cells, we extracted (for the most
abundantly cloned cellular miRNAs) the number of sequences
presenting with a tail of $3 nt, and calculated the ratio of these
values between MCMV and mock infected cells. Given that
miRNA tailing has been associated with their trimming, we also
performed the same analysis for sequences trimmed by at least 3
nt. We found that, in total RNA, miR-27b was significantly more
tailed in MCMV infected cells compared to mock infected cells
(4.35-fold) than any other cellular miRNA (median of ratio = 1.59)
(Figure 2E). The ratio for miR-27a was 2.00, which is above the
mean, but still inside the interquartile range. In addition, the
enrichment of tailed miR-27b in MCMV infected cells was lost in
Ago2 IP (Figure 2E). Only one other cellular miRNA, namely
miR-21, showed significantly enhanced 39 tailing in MCMV
infected cells (Figure 2E). As for miR-27b, this was only seen in
total RNA but not in the Ago2 IP. Regarding the trimmed
miRNAs, a strong enrichment (17.64-fold vs. a median ratio of
2.63) in MCMV infected cells compared to mock infected cells
could be seen for miR-27 (due to the trimming, these sequences
could not be attributed to either miR-27a or b). As for the tailed
sequences, this enrichment was lost in the Ago2 IP. Only one other
outlier, namely miR-434, showed an increased trimming in total
RNA of MCMV vs. mock infected cells. Interestingly, this miRNA
was also observed to be down-regulated in MCMV-infected cells
(data not shown). We were unable to resolve trimming of miR-27
by northern blot. Finally, we also looked at miRNAs tailed or
trimmed with $1 nt (Figure S2A), or $2 nt (Figure S2B), but did
not find a significant difference between MCMV infected cells and
non-infected cells for miR-27a and b. This is most probably due to
the fact that both miRNAs already show the addition of up to 2
nucleotides in mock-infected cells, thereby introducing substantial
variability and thus noise to our analysis. A global overview of all
modifications observed for miR-27a and b can be found in Table
S3.
Retargeting of m169 to other cellular and viral miRNAs
by target site replacement
In order to further characterize the mechanism of miR-27
degradation and obtain useful tools for further studies, we next
tested whether we could retarget m169 to other cellular or viral
miRNAs. We thus replaced the m169 binding site for miR-27 with
a binding site for the ubiquitous cellular miR-16, or for the highly
abundant viral miRNA mcmv-miR-M23-2 (Figure 3A). Binding
sites were designed to mimic the natural match-bulge-match
structure of the miR-27a binding site. We chose mcmv-miR-M23-
2 as we recently found this miRNA (together with mcmv-miR-21-
1) to be required for viral persistence in salivary glands [29]. After
generating the mutant viruses (MCMV-m169-miR-16 and
MCMV-m169-miR-M23-2) we performed a time-course of
infection in NIH-3T3 cells with these viruses and performed
northern blot analysis to probe for the effect of their retargeting on
miR-27, miR-16 and mcmv-miR-M23-2 levels (Figure 3B). As
expected, retargeting of m169 to other miRNAs by altering the
miR-27 binding site completely abolished the ability of both
mutants to mediate miR-27 degradation. In contrast, the MCMV-
m169-mut still showed a slight reduction of miR-27 levels
consistent with the ,2-fold reduction in miR-27 levels observed
by qRT-PCR (see Figure 1F). Apparently, the single G-C to A-C
change and the two A-U G-U changes to the seed region of the
m169 binding site were not sufficient to completely abolish miR-
27 binding. Most interestingly, this was accompanied by enhanced
tailing of miR-27, represented by the appearance of additional
bands on the northern blot. In contrast, complete disruption of this
binding site by retargeting it to either miR-16 or mcmv-miR-M23-
2 did not show this phenomenon. Together with the sequencing
data shown in Figure 2D, these data provide strong evidence that
miR-27 binding at this site mediates its tailing, either directly, or
by displacing it from its Argonaute protein.
Infection with MCMV-m169-miR-16 resulted in the rapid
degradation of miR-16 within the first four hours of infection. In
addition, infection with MCMV-m169-miR-M23-2 completely
abolished any detectable signal for mcmv-miR-M23-2 despite its
strong expression and continuous accumulation during lytic
MCMV infection (Figure 3B). Therefore, target site replacement
of this single miRNA binding site in m169 is sufficient to efficiently
target both cellular and viral miRNAs for rapid degradation.
Expression of m169 transcript alone is sufficient to target
miR-27 for degradation
To test whether any other viral factors were involved in miR-27
degradation, we generated replication-deficient adenoviral vectors
expressing either full-length m169 or its 39-UTR fused to EGFP
controlled by an EF1 promoter. An adenoviral vector expressing
mCherry served as negative control. NIH-3T3 cells were
transduced using an MOI of 50 or 500 (virus titers determined
using HEK-293 cells) in the presence of TransMAX reagent to
enhance transduction efficiency. Forty-eight hours after transduc-
tion of NIH-3T3 cells with these four adenoviruses, miR-27, miR-
24 and m169 transcript levels were determined by qRT-PCR.
Interestingly, expression of the 39-UTR of m169 fused to EGFP
was sufficient to mediate an MOI-dependent ,6-fold loss of miR-
27 levels (Figure 3C). This is in accordance with m169 transcript
levels being the highest in this condition but still 5- to 10-fold lower
than those achieved by lytic MCMV infection as determined by
qRT-PCR (data not shown). Therefore, expression of the 39-UTR
of m169 fused to a protein coding gene is sufficient to target a
cellular miRNA for degradation and no other viral factors appear
to be essential to this process.
As the 39-UTR of m169 was apparently sufficient to mediate
degradation of miR-27, we looked for additional motifs in it. We
accumulation over time in the same MCMV-infected NIH-3T3 cells. 18S rRNA was used as a loading control. C. Accumulation of miR-27a and miR-27b
in Ago2 IP and total RNA in mock (M) and from cells infected with MCMV for 6 and 12 hours. Signals were normalized to miR-16 and quantified
relative to mock-infected cells. D. Sequence logo representations for tailed miR-27a and 27b retrieved from deep-sequencing analysis of total RNA or
RNA extracted after Ago2 IP of mock or MCMV-infected cells (6 hpi). Only nucleotides 15 to 27 of miR-27 sequences presenting 39 addition are
represented, nucleotides of interest are depicted in colour, and the sizes of the largest tails are indicated next to the arrows. The genomic sequences
of pre-miR-27a and b are indicated underneath the sequence logo representations. E. Boxplot representation of the trimmed and tailed MCMV/mock
sequence ratios for the most abundant miRNAs shared by each library. Only sequences presenting with a 39-trimming or a -tailing of $3 nt in total
RNA or RNA extracted after Ago2 IP were considered. The outliers are indicated by black dots and miR-27a and b are indicated by a blue square and
an orange triangle respectively. The green dot indicates sequences that could not be annotated as either miR-27a or 27b due to their trimming. The
black bar indicates the median of all ratios.
doi:10.1371/journal.ppat.1002510.g002
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noticed a uridine-rich stretch located 69 nt 39 of the miR-27
binding site. Using markerless mutagenesis we mutated this stretch
from ‘UUUUUGUUUUUU’ to ‘AAGAAGAAAGAA’ in the
MCMV genome and reconstituted the mutant virus. However,
this did not alleviate degradation of miR-27 following high MOI
infection of NIH-3T3 fibroblasts (Figure S3).
m169 is a target of miR-27
While the m169 transcript obviously has a detrimental impact
on miR-27 or any other miRNA binding to it in a miR-27-like
manner, we needed to consider the option that the virus might
simply utilize an abundant cellular miRNA to regulate expression
of one of its genes. We thus investigated the effect of miR-27 on
Figure 3. Retargeting of m169 to cellular and viral miRNAs. A. Schematic representation of the miR-27a/m169 binding site and the
introduced mutated binding sites resulting in retargeting of m169 to either mmu-miR-16 or mcmv-miR-M23-2. Target site predictions were
performed using RNAhybrid to design the retargeting of m169. B. Efficient retargeting of m169 to a cellular and a viral miRNA. NIH-3T3 cells were
infected with the indicated viruses and total RNA isolated at different times of infection was analyzed by northern blot for miR-27, miR-16 and mcmv-
miR-M23-2. U6 served as loading control. Retargeting of m169 to miR-16 and mcmv-miR-M23-2 abolished degradation of miR-27 but resulted in
highly efficient degradation of the respective miRNAs. C. Expression of m169 39-UTR is sufficient to mediate miR-27 degradation. Adenoviral vectors
expressing either full-length m169 or its 39-UTR fused to EGFP were used to transduce NIH-3T3 cells at an MOI of either 50 or 500. An adenoviral
vector expressing mCherry was used as negative control. Two days post-transduction, total RNA was prepared and miR-24/miR-27 ratios were
determined by qRT-PCR.
doi:10.1371/journal.ppat.1002510.g003
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m169 RNA levels. First, we looked at m169 RNA levels following
infection with wild-type MCMV, MCMV-m169-mut, its rever-
tant, as well as the retargeted mutant MCMV-m169-miR-16.
Expression levels of m169 mRNA at 24 and 48 hpi were
determined relative to IE1 mRNA levels (to normalize for
differences in infection) using qRT-PCR. The level of m169
mRNA was significantly greater (,2-fold, p,0.001) for MCMV-
m169-mut than for the other three viruses (Figure 4A). This is
consistent with a partial loss of regulation of m169-mut by miR-
27 (resulting in increased m169 levels) and an efficient retargeting
of m169 by miR-16 which we found to be expressed at very
similar levels as miR-27 using qRT-PCR (data not shown). At
48 hpi no differences in m169 transcript levels were observed
anymore.
Figure 4. m169 is a target of miR-27. A. Effect on m169 RNA levels. To assess the effect of the miRNA/m169 interaction on m169 transcript levels,
NIH-3T3 cells were infected with wild-type MCMV, MCMV-m169-mut, its revertant as well as the retargeted mutant MCMV-m169-miR-16. At 24 and
48 hpi total RNA was prepared and m169 transcript levels were determined by qRT-PCR. In parallel IE1 RNA levels were quantified to normalize for
dose of infection. Disruption of the miR-27 binding site (MCMV-m169-mut) resulted in significantly increased (One-way anova analysis followed by
Tukey’s multiple comparisons test: ***: p,0.0001) m169 transcript levels at 24 hpi. This was restored when m169 was retargeted to miR-16 and no
longer seen at 48 hpi. B. Dual-luciferase assay with psiCHECK2 constructs containing either no UTR, a perfect match (PM) binding site for miR-27, the
wild type or the point mutant version of the m169 39UTR. HeLa WS cells were co-transfected with the luciferase construct and a control miRNA mimic,
or a miR-27a mimic. The ratios of normalized luciferase values for miR-27 and control mimics are indicated. ** p,0.001.
doi:10.1371/journal.ppat.1002510.g004
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We next assessed whether a luciferase sensor containing the
m169 39-UTR could be regulated by miR-27. We therefore
generated pSI-CHECK2 plasmids containing either a perfect
match to miR-27, the full-length m169 39UTR, or the point
mutant version of the 39 UTR that was used in the virus infection
experiment. These constructs were co-transfected into HeLa cells
with control or miR-27 miRNA mimics (to prevent any possible
down-regulation of the miRNA by these targets). As can be seen in
Figure 4B, the perfect match sensor for miR-27 was 80% down-
regulated by miR-27, while the m169 39-UTR reporter showed a
60% down-regulation. The insertion of the three point mutations
in the m169 39-UTR only partially alleviated its regulation by
miR-27 to about 40%, which is consistent with the 2-fold effect of
the respective mutant virus on miR-27 levels at 48 hpi. This
indicates that the m169-mut transcript can no longer efficiently
mediate miR-27 degradation, but is still partially regulated by
miR-27. In summary, these data indicate a complex mutual
interaction between miR-27 and m169.
The reciprocal interaction between miR-27 and m169 is
important for in vivo infection
As the interaction between the m169 transcript and miR-27a
appears to be mutual, the key question was whether the virus uses
the m169 transcript to target an important cellular miRNA for
degradation, or whether it simply uses an irrelevant but highly
expressed cellular miRNA to reduce and delay protein expression
of one of its genes. To address this question, we made use of our
mutant and retargeted viruses and studied their phenotypes
following 14 days of infection in mice. While we designed the three
point mutations in MCMV-m169-mut such as not to alter the
predicted m168 coding sequence, it is important to note that this
was not possible for both MCMV-m169-miR-16 and MCMV-
m169-miR-M23-2. For MCMV-m169-miR-M23-2 this altered six
amino acids in m168. For MCMV-m169-miR-16 this resulted in a
frame-shift and a premature stop codon 28 amino acids later (for
details see Table S4). So far nothing is known about the function of
m168, or whether it is expressed at all. However, we failed to
detect any expression of the m168 transcript even at late time-
points (both 24 and 48 hpi) of lytic MCMV infection of NIH-3T3
fibroblasts using next-generation sequencing (unpublished data).
We thus infected BALB/c mice for 14 days with these viruses and
determined virus titers in lungs. Interestingly, we observed a
significant 3- to 12-fold attenuation of all three viruses, the greatest
attenuation being observed for the m169-mut virus; no attenuation
was observed for the revertant virus MCMV-m169-mut-rev
(Figure 5A). This was also seen in BALB/c mice depleted for
both CD4+ and CD8+ T-cells, indicating that the observed
attenuation was independent of T-cell function. Next, we infected
SCID BALB/c mice with wild-type MCMV, MCMV-m169-mut,
or its revertant. At 14 days post infection (dpi) we again observed
significant (,10-fold) attenuation of this mutant virus in both lungs
and salivary glands (Figure 5B). We conclude that the quite
striking role of miR-27 during lytic MCMV infection is
independent of adaptive immunity. To test whether this
phenotype would become apparent even at earlier stages of acute
infection, we infected BALB/c mice for four days and compared
virus titers in lung and spleen. While virus titers in lungs showed
only a moderate, but consistent reduction in virus titers for all
three mutants no longer targeting miR-27, a strong 10- to 100-fold
attenuation of all three mutants was observed in spleen (Figure 5C).
Altogether, these data highlight that degradation of miR-27 by the
MCMV m169 transcript, and presumably also the miRNA-
mediated regulation of m169 protein expression are important
factors during lytic virus infection in vivo.
Discussion
Besides expressing large amounts of viral miRNAs shortly after
infection [21], MCMV also targets two cellular miRNAs for rapid
degradation, namely miR-27a and b [22]. Using a set of deletion
mutants and site directed mutagenesis, we show this effect to be
mediated by a single binding site located within the 39-UTR of a
so far uncharacterized, highly abundant, spliced MCMV tran-
script, namely m169. We found this effect to be readily redirected
to other cellular and viral miRNAs by target site replacement.
Interestingly, expression of the m169 39-UTR fused to EGFP by
an adenoviral vector was sufficient to mediate degradation of miR-
27, indicating that no other viral factors are essentially required in
this process.
Recently, Ameres et al. reported on tailing and trimming of
cellular miRNAs upon extensive base-pairing to their targets [14].
However, the underlying mechanism still remains to be deter-
mined. Thus, it is not known whether this is happening to
miRNAs still bound by an Argonaute protein, or after their
displacement from RISC. Upon wild-type MCMV infection, we
observed extensive tailing of miR-27 by northern blot within the
first few hours of infection, prior to its subsequent degradation.
The tailing and degradation of miR-27 was not observed in cells
infected with mutant viruses in which the miR-27/m169 RNA
interaction was disrupted by retargeting m169 to either miR-16 or
mcmv-miR-M23-2. This argues against a general effect of MCMV
infection on miR-27 tailing. Despite the point mutations we
introduced into the miR-27 binding site to generate MCMV-
m169-mut, the m169-mut transcript was still able to bind miR-27,
demonstrated by significant miR-27-mediated repression in dual-
luciferase assays. In addition, it still resulted in a somewhat
reduced but significant activity for miR-27 degradation (,2-fold
instead of ,30-fold) as observed by both qRT-PCR and northern
blot. Interestingly, we observed enhanced tailing of miR-27
following infection with MCMV-m169-mut compared to wild-
type MCMV infection. Most likely, this is due to the larger
amounts of miR-27 still present at 6–24 hpi. While these data thus
provide strong hints that binding of miR-27 to this single binding
site not only triggers its degradation but also its tailing, further
studies are required to clarify the link between the two.
Consistent with the northern blot data, small RNA deep-
sequencing revealed 39-tailing with 1 to 3 non-template nucleo-
tides for both miR-27a and miR-27b in uninfected cells. The
presence of non-template tailing is a common feature of miRNAs,
indicating that this is not unique to miR-27a/b. This was seen in
both total RNA as well as Ago2 IP samples independent of
MCMV infection. Upon MCMV infection, however, we observed
both an enhanced tailing of miR-27b, as well as trimming of miR-
27 ($3nt) in small RNA libraries prepared from total RNA.
Interestingly, this increased tailing and trimming of miR-27 was
not detectable in small RNA isolated from Ago2 IP samples, which
might indicate that these modifications occur after m169-mediated
displacement of miR-27 from Ago2, or that the tailed and
trimmed miR-27 forms are rapidly excluded from it. This is
partially corroborated by the northern blot analysis, which showed
a stronger MCMV-mediated down-regulation of miR-27 in Ago2
than in total RNA. The observation that miR-27b, and not miR-
27a, showed enhanced tailing might be due to its slightly weaker
interaction with m169, because a Watson-Crick base pair with the
m169 transcript is replaced by a G-U pairing. It is thus tempting to
speculate that we simply might have cloned and sequenced more
tailed miR-27b in MCMV infected cells because it is less efficiently
degraded than miR-27a – thereby either leaving less time for
tailing of miR-27a following displacement from Ago2, or speeding
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Figure 5. Degradation of miR-27 is important for efficient virus replication in vivo. BALB/c (A) or SCID BALB/c (B) mice were injected
intravenously (i.v.) with 16105 PFU of wild-type (wt), MCMV-m169-mut, m169-mut-rev or the two retargeted viruses MCMV-m169-miR-16 and –miR-
M23-2. Some of the BALB/c mice were depleted of CD4 and CD8 T cells. At 14 dpi organs were harvested and virus titers in lungs and salivary glands
determined by standard plaque assay. C. BALB/c mice were injected i.v. with 16105 PFU of indicated viruses. At 4 dpi organs were harvested and
virus titers in lungs and spleen determined by standard plaque assay. Viral titers in organs of individual mice (circles) and median values (horizontal
bars) are shown. DL= detection limit; * p,0.05; ** p,0.01.
doi:10.1371/journal.ppat.1002510.g005
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up displacement of tailed miR-27a from Ago2 followed by its more
rapid degradation. This would also explain the more rapid loss of
both miR-16 and mcmv-miR-M23-2 following infection with the
retargeted mutants, rendering tailing of these miRNAs below the
detection limit of our northern blots. Studies are ongoing to
address this important issue.
In a previous study [21], we already reported on extensive
tailing of two viral miRNAs, namely mcmv-miR-m21-1 and
mcmv-miR-M23-2, which was accompanied by a decrease of
these miRNAs late in infection. As we found these two miRNAs to
derive from a genomic locus transcribed from both the sense and
antisense strand, tailing and degradation of these two miRNAs
might result from binding to viral transcripts expressed from the
antisense strand. Together with the data presented in this study,
we therefore postulate that highly expressed transcripts, such as
MCMV m169, can cause miRNA tailing (and trimming) followed
by their degradation.
As m169 targets Argonaute-bound miR-27 for degradation, it
was very reasonable to assume that m169 may also serve as a
target for miR-27. Indeed we observed significantly higher m169
RNA levels following infection with MCMV-m169-mut than for
wild-type MCMV, its revertant, or MCMV-m169-miR-16.
Interestingly, this was only observed at 24 hpi, which was verified
in three independent experiments. In contrast, at 48 hpi when
wild-type MCMV infection has efficiently eliminated miR-27, its
effect on m169 expression was relieved. As such, the mutual
interaction between the m169 transcript and miR-27 is apparently
complex. The key question really was whether the main function
of m169 is to target an important cellular miRNA for degradation,
or whether the virus simply uses an irrelevant but highly expressed
cellular miRNA to reduce and delay protein expression of one of
its genes. With the help of our retargeted viruses we were able to
partially address this important question. Interestingly, all three
mutant viruses no longer able to efficiently target miR-27 for
degradation were significantly attenuated at 4 and 14 dpi in all
experiments we performed. This was particularly prominent in
both spleen at 4 dpi, and in lungs at 14 dpi. It is, however,
important to note that the generation of both MCMV-m169-miR-
16 and MCMV-m169-miR-M23-2 (but not MCMV-m169-mut)
resulted in alterations to the predicted m168 coding sequence.
While we were unable to detect m168 expression by next-
generation sequencing even at late times of infection (unpublished
data; data not shown) this does not rule out that alterations in
m168 may have contributed to the observed phenotype. In
addition, we cannot exclude that degradation of miR-16 by
MCMV-m169-miR-16 may have contributed to this phenotype.
In contrast, we recently provided an extensive set of data showing
that knock-out of mcmv-miR-M23-2 has no apparent effect on
lytic virus replication in various organs at 4 dpi and in lungs at
14 dpi [29]. The knock-out (which also includes the knock-out of
mcmv-miR-m21-1 which is generated from the antisense strand)
only resulted in significantly lower virus titers in salivary gland at
14 dpi. In the course of the current study we decided to generate
MCMV-m169-miR-M23-2 hoping to be able to further dissect the
phenotype of the miR-m21-1/-M23-2 double miRNA knock-out
virus in salivary gland [29]. However, as all three viruses no longer
able to efficiently target miR-27 for degradation also showed
significant attenuation in salivary gland at 14 dpi, this aim could
not be achieved. In conclusion, it may thus well be that other
factors than degradation of miR-27 contributed to the attenuation
of the different mutants we observed. In particular the role of miR-
27 in controlling the timing of m169 expression requires further
studies. This and other factors are likely to have contributed to the
attenuation of our three mutant viruses. However, as all three
mutants deficient for miR-27 degradation were attenuated in vivo
we believe this provides good evidence that degradation of miR-27
is indeed important during acute MCMV infection in vivo.
So far little is known about the function of miR-27. Our data
provide strong evidence that miR-27 expression is harmful to
productive MCMV infection. Interestingly, the Steitz laboratory
recently showed that the oncogenic herpesvirus saimiri also uses
one of its non-coding RNAs to target miR-27 for degradation [23].
This supports the interpretation of our data that degradation of
miR-27 is indeed of importance for MCMV, and probably also for
herpesvirus saimiri. The mechanism by which degradation of
miR-27 aids lytic MCMV infection still remains elusive. To date,
these two miRNAs have been implicated in pathways such as cell
differentiation [30], adipogenesis [31], and angiogenesis [32].
Among the validated cellular targets, the tumor suppressor
FOXO1, which is involved in controlling the cell cycle through
CDKN1C induction [33], might provide a link to the strong
phenotype we observed during acute MCMV infection. Indeed,
cytomegaloviruses are known for their manipulation of the cell
cycle [34], and m169 may act by releasing the effects of miR-27 on
cell cycle progression. Interestingly, recent reports showed that the
level of the miR-16 family of miRNAs are efficiently destabilized
in response to cell-cycle changes [35]. Therefore, rapid alterations
in cellular miRNAs are likely to be of importance in the regulation
of cell cycle progression.
Why does m169 so efficiently target miR-27 for degradation?
We noted m169 to be expressed at extremely high levels within
4 h of infection, exceeding levels of IE1 by .20-fold at 24 h post
infection. The number of m169 transcripts obviously matters.
Mutagenesis of a uridine-rich motif, which we observed in close
proximity to the miR-27 binding site, had no effect on miR-27
degradation. The shift from a classical miRNA-target interaction,
where the miRNA regulates its target, and the opposite effect, i.e.
miRNA degradation mediated by its RNA target, might thus
simply be controlled by the relative abundance of the target RNA.
When the m169 transcript reaches a certain level, it may thus start
to trigger degradation of miR-27, ultimately avoiding its
regulatory effect. Further studies are required to address this
interesting question.
In conclusion, there is now increasing evidence that the
expression of miRNAs is strongly regulated, and that these
molecules are not as stable as they were once thought to be. They
are part of a sophistically tuned, complex reciprocal interaction
network with the mRNA targets they regulate. The ability of
cytomegalovirus to usurp the underlying cellular machinery by
expressing decoy targets which bind to specific miRNAs and
degrade them is yet another illustration of the fascinating
dynamism of RNA-mediated regulation.
Materials and Methods
Ethics statement
All of the protocols used for breeding of mice and different kinds
of treatments were approved by the Ethical Committee of the
Faculty of Medicine University of Rijeka and were performed in
accordance with Croatian Law for the Protection of Laboratory
Animals, which has been harmonized with the existing EU
legislation (EC Directive 86/609/EEC).
Cell lines
BALB/c murine embryonic fibroblasts (MEFs) and M2-10B4
bone marrow stroma cells (ATCC: CRL-1972) were cultured in
DMEM containing 10% fetal calf serum and penicillin/strepto-
mycin. NIH-3T3 fibroblasts (ATCC: CRL-1658) were cultured in
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DMEM medium containing 5% fetal calf serum and penicillin/
streptomycin.
Generation of mutant viruses
Generation of deletion mutants to screen for the gene
responsible for miR-27a/b degradation was performed as
described previously [36] using the full-length MCMV BAC
pSM3fr [37]. All PCR primers are included in Table S5A.
Markerless BAC mutagenesis was performed to introduce more
subtle changes into the MCMV m169 locus. This was performed
according to previously published protocols [38,39]. Briefly, an I-
SceI-aphAI cassette was amplified from the plasmid pEPKAN-S
by 2-step PCR using the different sets of primers included in Table
S5B. In the first Red recombination step these PCR fragments
were inserted into pSM3fr, resulting in a BAC carrying a
kanamycin resistance cassette flanked by I-SceI restriction sites.
The kanamycin resistance cassette was then removed from
kanamycin-resistant clones by an arabinose-induced I-SceI
digestion and subsequent heat-induced Red recombination,
resulting in markerless mutagenesis of the miR-27a/b binding
site in m169. The revertant virus (MCMV-m169-mut-rev) was
generated from the m169-mut BAC by completely restoring the
wild-type sequence, i.e. reverting all three point mutations to wild-
type sequence. All mutant BACs were subjected to extensive
restriction pattern analysis using at least three different restriction
enzymes followed by sequencing of the altered m169 locus. All
viruses were reconstituted by transfecting the recombinant BACs
into murine embryonic fibroblasts and virus titers were determined
on MEFs by standard plaque assay as described [36].
Generation of adenoviruses expressing full-length or
parts of m169
Adenoviral vectors expressing either full-length m169, or its 39-
UTR fused to EGFP under control of the cellular EF1-promoter
were generated by Sirion Biotech, Martinsried, Germany. An
adenovirus expressing mCherry served as control. To increase
transduction efficiency of NIH-3T3 cells, TransMAX enhancer
reagent (Sirion Biotech) was used following the manufacturer’s
instruction using an MOI of 50 and 500 (titers derived from
infection of HEK-293 cells, corresponding to an MOI of about 5
and 50 in NIH-3T3 cells).
Infection of NIH-3T3 cells
Six-well plates were seeded with 0.56106 cells one day prior to
infection in DMEM containing 10% fetal calf serum. Cells were
infected with indicated viruses at an MOI of 1 followed by
centrifugal enhancement (800 g, 30 min), resulting in an effective
MOI of ,10; culture media was replaced following one hour of
infection.
Quantifying changes in miRNA levels by qRT-PCR
NIH-3T3 cells were infected with wild-type MCMV or mutant
viruses at an MOI of 10. 48 h post infection RNA was prepared
using either Trizol reagent (Invitrogen) or miRNeasy columns
(Qiagen) following the manufacturers’ instructions. cDNA was
prepared in a single step reaction for both miRNAs and larger
transcripts using the miScript Reverse Transcription kit (Qiagen).
Light Cycler qRT-PCR was performed for various cellular and
viral miRNAs using the miScript SYBR Green PCR kit (Qiagen)
following the manufacturer’s instructions. In each case the
nucleotide sequence of the mature target miRNA was used to
design the miRNA-specific forward primer. The PCR program
was composed of a denaturation step at 94uC for 12 min followed
by 45 cycles of 95uC for 15 sec (ramp rate 20uC/sec), 55uC for
30 sec (ramp rate 20uC/sec; 60uC for mRNA targets) and 70uC
for 1 sec (ramp rate 2uC/sec). A list of all PCR primers is provided
in Table S5C.
Immunoprecipitation of mouse Argonaute 2 complexes
To determine whether the m169 transcript was recruited to
Ago2-complexes, immunoprecipitation of miRNA/target com-
plexes was performed using the recently published antibody to
mouse Ago2 [40]. Per replicate, ten large (15 cm) dishes of NIH-
3T3 cells were infected with an MOI of 10 for 0, 6 or 12 h with
wild-type MCMV. Cells were washed twice with PBS before lysis
in 10 ml lysis buffer, containing 25 mM Tris HCl pH 7.5,
150 mM KCl, 2 mM EDTA, 0.5% NP-40, 0.5 mM DTT, and
Complete protease inhibitor (Roche). DTT and protease inhibitors
were always prepared freshly and added immediately before use.
Lysates were incubated for 30 min at 4uC and cleared by
centrifugation at 20,000 g for 30 min at 4uC. Total RNA was
prepared from 100 mL of cell lysates using the miRNeasy kit
(Qiagen) following the manufacturer’s instructions. Ago2-immu-
noprecipitation was performed as recently described [41]. In short,
6 mg of purified monoclonal mAgo2-antibody (2D4, Wako) or
monoclonal BrdU-antibody (abcam; used as control) was added to
5 mL of RPMI-medium and incubated with 30 mL of Protein-G-
Sepharose beads (GE Healthcare) in Pierce centrifuge columns
(Thermo Scientific) under constant rotation at 4uC over night.
Columns were drained by gravity flow and washed once with the
lysis buffer. Beads were subsequently incubated with 5 mL of cell
lysates for 2.5 h under constant rotation at 4uC. After incubation,
the beads were washed four times with IP wash buffer (300 mM
NaCl, 50 mM Tris HCl pH 7.5, 5 mM MgCl2, 0.1% NP-40,
1 mM NaF) and once with PBS to remove residual detergents.
RNA was recovered from the beads by adding 700 ml of Qiazol to
the columns. After 5 min the Qiazol lysates were collected from
the columns. This step was repeated once and the Qiazol lysates
were combined. RNA was prepared using the miRNeasy kit
(Qiagen) according to the manufacturer’s instructions. RNA
samples were eluted in 30 mL of H2O. Efficiency of the
immunoprecipitation was checked by qRT-PCR for miR-16 and
let7a.
Northern blot analysis
Small RNAs. RNA was extracted using Trizol and northern
blotting was performed on 10 mg of total RNA. Briefly, total RNA
was resolved on a 17.5% acrylamide gel of 30 cm in length. RNAwas
transferred by semi-dry transfer (BioRad TransBlot SD) to aHybond-
NXmembrane (GE Healthcare). RNAs were then cross-linked to the
membrane by EDC cross-linking as described in Pall and Hamilton
[42] with a 90 min incubation step at 65uC. Prehybridization,
hybridization, and wash steps were performed at 50uC. Probes either
consisted of 59-32P-radiolabelled oligodeoxynucleotides only or
oligodeoxynucleotides containing Locked Nucleic Acid positions for
the detection of tailed forms of miR-27 (Eurogentec). They are
perfectly complementary to the miRNA sequence or to part of the U6
snRNA sequence.
m169 transcript. Total RNA samples (1 mg) were mixed
with equal volumes of loading dye and heated at 65uC for
10 minutes prior to separation on a 1.2% agarose/formaldehyde
gel. RNA was transferred overnight to a Hybond-NX membrane
(GE Healthcare) by standard capillary transfer methods and
crosslinked with UV. Membranes were prehybridized for 2 hrs in
PerfectHybTM plus (Sigma) at 50uC. Antisense DNA oligos for
m169 (59-GGACGGGGGGAGACGGCGGACGAG) and mouse
18S (5-CGGAACTACGACGGTATCTG) were 59 end labelled
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using T4 polynucleotide kinase (Fermentas) with 25 mCi of [c-
32P]dATP. The labelled probe was hybridized to the blot
overnight at 50uC. The blot was then washed at 50uC twice for
20 min (56SSC/0.1% SDS), followed by an additional wash (16
SSC/0.1% SDS) for 20 min.
Northern blots were exposed to phosphorimager plates (Fuji)
and scanned using a FLA-5000 series phosphorimager (Fuji).
Small RNA cloning and sequencing
To assess the role of MCMV in the regulation of miR-27, four
small RNA libraries were generated, either from total RNA, or
from small RNAs immunoprecipitated with Ago2. For libraries
generated from total RNA, 10 mg of total RNA was used in the
initial step. For libraries generated from small RNAs incorporated
into Ago2 containing RISC complexes, a fraction of the mAgo2
IPs from either MCMV infected (6 hpi), or control cells were used.
Samples were size fractionated on a 17.5% PAGE gel, and small
RNAs between 19 and 33 nt were excised and cloned as previously
described [43], except that small RNA PCR products were not
concatamerized, and instead sent directly for sequencing. Small
RNA libraries were sequenced at the Institut de Ge´ne´tique et de
Biologie Mole´culaire et Cellulaire (IGBMC, Illkirch, France) using
an Illumina Genome Analyzer IIx with a read length of 36 nt.
Deep-sequencing data analysis
Short sequences generated by the Illumina platform were pre-
processed and annotated using an in-house pipeline, specifically
designed to detect miRNA variants. We first applied the
Dustmasker program [44] to filter out low complexity reads,
before removing the 39 adaptor from the remaining sequences
using the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_
toolkit). Trimmed reads of 15 to 32 nt in length were then
selected to be mapped simultaneously to the mouse (UCSC
repository - assembly version mm9) and the MCMV (RefSeq
database - accession number NC_004065.1) genomes using
Bowtie [45] by permitting up to 1 mismatch in the first 15 read
nucleotides and no limit beyond. Reads that could map to more
than 20 loci were discarded and a post-filtering was applied to
keep only the best alignment(s) of each small RNA sequence
provided this (these) alignment(s) did not exceed a total number of
9 mismatches compared to the reference genome. From there, all
known mature and star miRNAs derived from Mus musculus and
MCMV (miRBase v.17) were annotated by comparing their
genomic coordinates to that of the reads, and by keeping reads
with at least 50% of their length inside the genomic feature. By
doing so, we were able to inventory and quantify all miRNA
forms: full length, 39-trimmed, 39-tailed, 59-trimmed, 59-tailed and
every possible combination (59-trimmed+39-trimmed, 59-
trimmed+39-tailed, 59-tailed+39-trimmed and 59-tailed+39-tailed),
may they be identical or different to the template sequence.
During the quantification process, multiple mapped reads were
weighted by a factor 1/n, n being the number of alignments they
were respectively involved in. To determine the nature of the
modifications affecting miR-27a and miR-27b upon infection,
these two miRNAs were more precisely analyzed and manually
curated to redistribute the few sequences that were mis-annotated
between the two forms. These mis-annotations were most
probably due to the poor constraints applied on the 39 read ends
during the mapping step.
The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus and are accessible through
GEO Series accession number GSE34475 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE34475).
For the generation of sequence logo representations and for the
comparison of libraries, sequencing data were normalized per
million miRNA reads. In addition, only sequences that were
cloned at least once per 16106 miRNA reads were considered to
produce Figure 2D, Table S1 and Table S2. For Figure 2E and
Figure S2, we first determined the 100 most abundant miRNAs in
each library before selecting those that were common to all four
libraries. We then extracted their respective tailed (only non-
template additions were considered) and trimmed sequences, and
in both cases we only kept modified miRNAs that were
represented by at least 1 read per million miRNA reads in all
four libraries. Finally, we calculated the sequence ratios for each
selected miRNA between MCMV and mock infected libraries,
and generated boxplot graphs. For Table S3, raw sequences of
miR-27a and b prior to any filter were taken into account.
Mice
BALB/c (H-2d) and SCID BALB/c (H-2d) mice were housed
and bred under specific-pathogen-free conditions at the Central
Animal Facility, Faculty of Medicine, University of Rijeka.
Luciferase assays
HeLa WS cells were seeded in 48-well plates at 25,000 cells/
well and then incubated for 24 h. Cells were then co-transfected
using Lipofectamine 2000 (Invitrogen) with 25 ng of the reporter
constructs, 250 ng of carrier pUC19 DNA and 10 nM of miRNA
mimic (cel-miR-67 as a control or miR-27a). After 24 h, cells were
then washed in PBS and lysed with 65 mL of passive lysis buffer
(Promega), and 10 mL were assayed for Firefly and Renilla
luciferase activity, using the dual-luciferase reporter assay system
(Promega) and a luminescence module (Glomax, Promega). The
relative reporter activity was obtained by first normalizing to the
transfection efficiency with the Renilla activity, and then, to the
firefly activity obtained for the empty control reporter, in presence
of the miR-27 mimic or control mimic, to normalize for the effect
of transfection of these oligonucleotides. Finally, the ratios of the
values obtained for miR-27 and control mimics were calculated.
Infection conditions and detection of infectious MCMV in
tissues, depletion of lymphocyte subsets and statistical
evaluation
Mice were injected intravenously with 16105 PFU of tissue culture-
grown wild-typeMCMVor recombinant viruses in 0.5 mL of diluent.
Organs were collected either 4 or 14 days after infection and virus
titers were determined by a standard plaque-forming assay [46]. In vivo
depletion of B and T cells was performed by intraperitoneal injection
of the mAbs to CD4 (YTS191.1), to CD8 (YTS 169.4) molecules [47].
Statistical significance of the difference between experimental groups
was determined by the Mann-Whitney exact rank test.
Accession numbers of genes
The following murine genes were mentioned in the text:
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; NM_0080
85.1), Lamin B receptor (LBR; NM_133815.2), Interferon regulatory
factor 1 (IRF1; NM_008390.2), mmu-miR-27a (MIMAT0000537),
mmu-miR-27b (MIMAT0000126), mmu-miR-24 (MIMAT0000
219), mmu-miR-16 (MIMAT0000527).
Supporting Information
Figure S1 Annotated nucleotide sequence of the m169
transcript (Smith strain).
(TIF)
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Figure S2 Boxplot representations of the trimmed and
tailed MCMV/mock sequence ratios for the most
abundant miRNAs common to all libraries. Only sequenc-
es trimmed or tailed by $1 nt (A) or $2 nt (B) in total RNA or
RNA extracted after Ago2 IP were considered. The outliers are
indicated by black dots and miR-27a and b are indicated by a blue
square and an orange triangle, respectively. The black bar
indicates the median of all ratios.
(TIF)
Figure S3 Mutagenesis of the pyrimidine-rich stretch
close to the miR-27 binding site has no significant effect
on miR-27 degradation. To generate MCMV-m169-URS-
mut, the pyrimidine-rich stretch located 69 nt 39 of the miR-27
binding site was mutated from ‘TTTTTGTTTTTT’ to ‘AA-
GAAGAAAGAA’ using markerless mutagenesis. The primers
used to amplify the Kanamycin resistance gene encoded on the
plasmid pEPKAN-S are included in Table S5. Following virus
reconstitution, NIH-3T3 cells were infected with mock, m169-
URS-mut or wild-type MCMV (WT) at an MOI of 10. At 48 hpi
miR-24 and miR-27 levels were determined by q-RT-PCR. No
significant difference in miR-27 degradation between m169-URS-
mut and wild-type MCMV infection was observed.
(TIF)
Table S1 miR-27a Sequences from total RNA and Ago2-
IP used to generate Figure 2D. Sequences that were used to
generate the sequence logo representation of miR-27a in
Figure 2D. The full-length sequence is indicated in grey at the
top of the list, and sequences presenting with 39 additions are listed
afterward. For each sequence, the size and the normalized number
of reads (per million miRNA reads) are indicated. Only sequences
cloned at least once per 16106 miRNA reads were taken into
account.
(XLS)
Table S2 miR-27b Sequences from total RNA and Ago2-
IP used to generate Figure 2D. Sequences that were used to
generate the sequence logo representation of miR-27b in
Figure 2D. The full-length sequence is indicated in grey at the
top of the list, and sequences presenting with 39 additions are listed
afterward. For each sequence, the size and the normalized number
of reads (per million miRNA reads) are indicated. Only sequences
cloned at least once per 16106 miRNA reads were taken into
account.
(XLS)
Table S3 Modifications (Tailing/Trimming) of miR-27a
and b sequences in total RNA and Ago2-IP. Representation
of all observed modifications of miR-27a and b in the deep-
sequencing libraries. fl: full length; id: identical (similar to genomic
sequence); iso: isoform (differs from genomic sequence); 3trim: 39
trimmed; 3add: 39 tailed; 5trim: 59 trimmed; 5add: 59 tailed. The
normalized number of reads (per million miRNA reads) is
represented as well as the ratio in percentage relative to the other
modifications.
(XLS)
Table S4 Changes in nucleotide sequence of the differ-
ent mutants and their impact on the putative m168
coding sequence. Changes in nucleotide sequence and in the
encoded aminoacids are shown.
(XLSX)
Table S5 List of all primers used for PCR or cloning.
Primers used for generation of MCMV deletion mutants using
ET-cloning (A), for the generation of MCMV mutants using
Markerless mutagenesis (B) and for qRT-PCR (C) are shown.
(XLSX)
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